FY26 UDO initiative - niddk: supply: wizard 2 gamma counter w/5-DET, 550 smpl - severable

Ended Purchase Order Awarded Last action

Contract number
75N94025P00648
Awardee
Awarding agency
Obligated
$66,858

Award facts

Opportunity
  • 75N94025Q00231 Solicitation number
Contract value 100% obligated
$66,857.71 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health, Department of Health and Human Services
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Competed under SAP · 4 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Hopkinton, MA 01748, USA

Award details come from SAM.gov/FPDS.

About this award

The National Institute of Diabetes and Digestive and Kidney Diseases awarded a $66,857.71 firm fixed-price purchase order to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) on September 25, 2025, for the procurement of a WIZARD 2 Gamma Counter with five detectors and 550-sample capacity. The contract, which supports the FY26 Undiagnosed Diseases Organization Initiative, is severable in nature and does not utilize a small business set-aside. Performance will be completed at the contractor's location in Hopkinton, Massachusetts, with an ultimate completion date of November 14, 2025. This purchase order represents a routine equipment procurement for scientific research and diagnostic purposes consistent with NIDDK's mission to support biomedical research.

Revvity Health Sciences is an established large business contractor with extensive experience supplying specialized laboratory instrumentation and scientific equipment to federal agencies across the National Institutes of Health, Centers for Disease Control and Prevention, Department of Veterans Affairs, and other civilian agencies. The WIZARD 2 Gamma Counter is a standard analytical instrument used in biomedical research for measuring radioactive samples, making it appropriate for the diabetes and kidney disease research initiatives supported by NIDDK. The award is classified as a child contract, indicating it may be issued under an existing indefinite delivery vehicle or master agreement. Revvity's proven track record in equipment procurement and maintenance services positions it well to deliver and support this specialized research instrument.

Quick answers

Who was awarded contract 75N94025P00648?

75N94025P00648 was awarded to Revvity Health Sciences, Inc. by National Institute of Child Health and Human Development (National Institutes of Health) on September 25, 2025.

How much is contract 75N94025P00648 worth?

The government has obligated $66,858 on 75N94025P00648.

Which agency awarded contract 75N94025P00648?

National Institute of Child Health and Human Development (National Institutes of Health) awarded 75N94025P00648, with funding from National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health).

Was contract 75N94025P00648 competed?

The extent of competition for 75N94025P00648 was competed under sap. The government received 4 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award